The 2025 US biotech event landscape presents a dynamic intersection of investor-driven conferences and scientific symposia, each catering to distinct objectives and fostering different types of collaborations crucial for industry growth and innovation.

US biotech firms can maximize their return on investment at BIO International 2025 by implementing focused pre-event planning, strategic networking, effective pitching, and post-event follow-up to convert connections into tangible business outcomes.